Search results
Here's Why Wit Studio Is Remaking One Piece; EXPLAINED
Pinkvilla· 2 days agoFans were surprised but delighted to find out that Wit Studio is going to remake the phenomenal...
This festive season, mission is possible: Companies to stockpile weapons of mass consumption
The Economic Times· 5 days agoKolkata|New Delhi: Companies making smartphones, refrigerators, wearables and two-wheelers said they...
Ola founder Bhavish Aggarwal on Tesla reportedly not investing in India: If true, this is Tesla’s...
The Times of India· 2 days agoOla founder and CEO Bhavish Aggarwal said that Tesla’s pullback from India, if true, is a loss for...
Pingree launches congressional caucus to push back against ‘fast fashion’
Maine Morning Star· 5 days agoU.S. Rep. Chellie Pingree last week announced the formation of a “slow fashion caucus” meant to...
Go Fashion (India) Ltd Management Discussions | India Infoline
India Infoline· 2 days agoOverview: The global economic growth was estimated at a slower 3.2% in 2022, compared to 6% in 2021 (which was on a smaller base of 2020 on account of the pandemic effect). The relatively < ...
Govt looks at easing FDI rules further
Financial Express· 2 days ago“Internal discussions on,” says DPIIT secretary, as Budget preparation is under way.
Astec Lifesciences Ltd Management Discussions | India Infoline
India Infoline· 2 days agoGlobal economic growth significantly slowed in 2022 due to various factors including elevated commodity prices, energy supply concerns in Europe, fallout from prolonged Russia-Ukraine conflict ...
Kalki 2898 AD Box Office Collection Day 5: Numbers drop 60% on Monday; Prabhas’ movie still manages...
Livemint· 5 days agoKalki 2898 AD Box Office Collection Day 5: Prabhas, Deepika Padukone, Amitabh Bachchan, Kamal Hassan...
Garudan OTT Release: Here's when and where you can watch Soori and Unni Mukundan's action-thriller
Pinkvilla· 5 days agoThe Tamil film industry saw a slow start in 2024, with no major releases except for the re-release...
5 FDA decisions to watch in the third quarter
BioPharma Dive· 4 days agoMultibillion-dollar buyouts from Bristol Myers Squibb and Gilead could yield new drugs for brain and liver diseases, while a new cell therapy may reach...